drug

levoketoconazole

Marketedupdated 2mo ago

by $XERS Xeris Biopharma Holdings, Inc.

Approved

community read0 votes

all catalysts(0)

nothing on the calendar yet

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 25m ago

Found something off?

Patent cliff

source: FDA Orange Book

first barrier falls

Dec 30, 2026

176 days

Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.

patents (9)

Mar 2, 2040method-of-use (U-3282)US 11020393
Mar 2, 2040method-of-use (U-3282)US 11278547
Mar 2, 2040method-of-use (U-3821)US 11903940
Mar 2, 2040method-of-use (U-4236)US 12377096
May 3, 2028method-of-use (U-3283)US 99189841.8y
Jan 10, 2026method-of-use (U-3283)US 10098877
Jan 10, 2026method-of-use (U-3283)US 10517868
Jan 10, 2026method-of-use (U-3283)US 10835530
Jan 10, 2026method-of-use (U-3283)US 11478471

FDA exclusivities (2)

Dec 30, 2028ODE-385Orphan Drug (7y)2.5y
Dec 30, 2026NCE*NCE*176d

comments(0)

5-min edit window · permanent after that

sign in to leave a comment · permanent archive after 5 minutes

no comments yet — first sniff?

Trials studying levoketoconazole

phase3Open-label Treatment in Cushing's Syndromecompletedn=51